Multi-Centre UK Analysis of Simultaneous Pancreas and Kidney (SPK) Transplant in Recipients With Type 2 Diabetes Mellitus
Ruth Owen, Harry Carr, Claire Counter, Samuel J Tingle, Emily Thompson, Derek Manas, James Shaw, Colin Wilson, Steve White
Abstract
90% of the UK diabetic population are classified as T2DM. This study aims to compare outcomes after SPK transplant between recipients with T1DM or T2DM. Data on all UK SPK transplants from 2003–2019 were obtained from the NHSBT Registry ( n = 2,236). Current SPK transplant selection criteria for T2DM requires insulin treatment and recipient BMI < 30 kg/m 2 . After exclusions (re-transplants/ambiguous type of diabetes) we had a cohort of n = 2,154. Graft (GS) and patient (PS) survival analyses were conducted using Kaplan-Meier plots and Cox-regression models. Complications were compared using chi-squared analyses. 95.6% of SPK transplants were performed in recipients with T1DM ( n = 2,060). Univariate analysis showed comparable outcomes for pancreas GS at 1 year ( p = 0.120), 3 years ( p = 0.237), and 10 years ( p = 0.196) and kidney GS at 1 year ( p = 0.438), 3 years ( p = 0.548), and 10 years ( p = 0.947). PS was comparable at 1 year ( p = 0.886) and 3 years ( p = 0.237) and at 10 years ( p = 0.161). Multi-variate analysis showed comparable outcomes in pancreas GS ( p = 0.564, HR 1.221, 95% CI 0.619, 2.406) and PS( p = 0.556, HR 1.280, 95% CI 0.563, 2.911). Comparable rates of common complications were demonstrated. This is the largest series outside of the US evaluating outcomes after SPK transplants and shows similar outcomes between T1DM and T2DM recipients. It is hoped dissemination of this data will lead to increased referral rates and assessment of T2DM patients who could benefit from SPK transplantation.